Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Current research explores hair growth drugs, while future research aims for personalized treatments.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

People with HIV and low T cell counts have more hair and scalp problems.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

People with alopecia areata are more likely to have other immune-related conditions.

Keratosis pilaris is often linked to genetic mutations and causes skin and hair abnormalities, regardless of those mutations.

Granulomatous Alopecia Areata is rare and may be caused by hair antigens or follicle destruction.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Recent dermatological research highlights include new virus discoveries, genetic links to skin conditions, and insights into skin healing and pigmentation.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

North American ginseng extract helped regrow hair in balding mice.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

γδ T cells adapt uniquely to different tissues in mice.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

UV light helped human hair transplants survive in mice without broad immunosuppression.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.